Memorial Sloan Kettering Cancer Center 10th Annual MSK Symposium on Lymphoma 2026

Description

+ Include: videos + file sub vtt + pdfs, size: GB
+ Target Audience: internists, hematologists, medical and radiation oncologists, hematopathologists
+ Sample video: contact me for sample video
+ Information:
Join us for the 10th anniversary edition of the MSK Symposium on Lymphoma, marking a decade of advances in lymphoma diagnosis, management, and therapy. This one-and-a-half-day symposium will explore the rapidly evolving landscape of lymphoma research and clinical practice, highlighting advances in disease biology, diagnostic approaches, and therapeutic strategies that are transforming patient outcomes.
The program offers a comprehensive review of the clinical management of both common and emerging lymphoma subtypes. Through expert-led lectures, interactive panel discussions, and practical clinical guidance, faculty will share the latest evidence and insights to support informed, individualized decision-making in an era of accelerating innovation. Key highlights include:

Keynote Lectures: Presented by internationally recognized leaders in lymphoma biology, translational research, and clinical care.
Interactive Panel Discussions: Case-based conversations addressing evolving treatment paradigms and real-world clinical challenges.
Allied Health Professionals Session: A dedicated session for the interprofessional care team, highlighting their essential and expanding role in lymphoma management. Please note that space is limited for this session.

Participants will gain insight into the scientific advances shaping lymphoma biology and pathology, and how these discoveries are being translated into clinical practice. This program brings together distinguished experts from MSK and institutions across the United States and around the world to advance education, collaboration, and patient-centered care—helping to shape the future of lymphoma care.
Course Date: Friday, April 10, 2026, 8:00 AM – Saturday, April 11, 2026, 2:00 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY
Learning Objectives

Describe recent advances in lymphoma diagnosis, helping navigate with recent advances in the WHO and ICC classifications
Discuss first line treatment options in most frequent lymphoma entities
Describe new agents mode of actions, efficacy, side effects
Discuss options and recommendations for patients in the relapse refractory setting
Provide strategies to help shared decision-making with patients regarding their treatment

Target Audience

This symposium is designed for internists, hematologists, medical and radiation oncologists, hematopathologists, scientists, and medical trainees who are involved in the diagnosis, treatment, and biomedical research of lymphoma. Participants have the option to attend in person or virtually.

Topics

A “Path” Toward Diagnosis- An Overview of Pathology in Lymphoma

Advances in Therapeutic Strategies for Mantle Cell Lymphoma

Bridging, Debulking, and Beyond- The Multifaceted Role of Radiotherapy with CAR T Cells and Bispecifics

CAR T-Cell Therapy- Lessons Learned from the DESCAR-T Registry

Concepts and Controversies in Aggressive B-Cell Lymphoma Classification

Current Challenges in the Management of Patients with Follicular Lymphoma

Debate- Is a Follicular Lymphoma Cure in Reach- T-Cell Engagers versus CAR T-Cell Therapy

Diffuse Large B-Cell Lymphoma- Diagnosis and Updates on Management

Diffuse Large B-Cell Lymphoma Panel Discussion and Q&A

Follicular Lymphoma Panel Discussion and Q&A

Hodgkin Lymphoma Panel Discussion and Q&A

HTLV-1 Clinic Overview

HTLV-1-Associated Lymphoma-Leukemia- Biology

HTLV-1-Associated Lymphoma-Leukemia- Epidemiology and Natural History

HTLV-1-Associated Lymphoma-Leukemia- Therapies

Innovations in T-Cell Lymphoma- A Winding Road

Insights into the Molecular Classification of Diffuse Large B-Cell Lymphoma

Integrative Medicine- Management of Treatment Related Side Effects

Introduction to Cutaneous T-Cell Lymphoma

Lessons Learned from the Development of T-Cell-Engaging Antibodies in B-Cell Lymphoma

Mantle Cell Lymphoma Panel Discussion and Q&A

Mechanisms of Resistance to BTK Degraders

Optimizing First-Line Therapy- Balancing Efficacy versus Toxicity

Optimizing First-Line Therapy in Diffuse Large B-Cell Lymphoma

Panel Discussion and Q&A

Plenary Lecture- Designing the Next Generation of CAR T-Cell Therapies for Lymphoma

Plenary Lecture Panel Discussion and Q&A

Recent Advances in the Management of Chronic Lymphocytic Leukemia

Research Spotlight- Bispecific B Cell Protocols at MSK and CRS management

Skin Considerations for Cutaneous T-Cell Lymphoma

Small Doses, Big Impact- The Role of Very Low-Dose Radiotherapy in Potentially Curable Indolent Lymphomas

Special Lecture- B-Cell Development and Lineage Stability

Special Lecture- How to Interpret “Real-World” Data

Spotlight on New Agents and MSK Clinical Trials

Spotlight on Nodular Lymphocyte Predominant B-Cell- Hodgkin Lymphoma

Spotlight on Recent Drugs and MSK Clinical Trials – 01

Spotlight on Recent Drugs and MSK Clinical Trials

T-Cell Lymphoma Panel Discussion and Q&A